KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Change in Acquisitions & Divestments: 2009-2025

Historic Change in Acquisitions & Divestments for Novavax (NVAX) over the last 11 years, with Sep 2025 value amounting to $100.5 million.

  • Novavax's Change in Acquisitions & Divestments fell 4.84% to $100.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $593.1 million, marking a year-over-year increase of 58.37%. This contributed to the annual value of $443.6 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Novavax reported Change in Acquisitions & Divestments of $100.5 million as of Q3 2025, which was down 9.97% from $111.6 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Change in Acquisitions & Divestments peaked at $337.9 million during Q4 2024, and registered a low of $2.2 million during Q2 2021.
  • In the last 2 years, Novavax's Change in Acquisitions & Divestments had a median value of $105.6 million in 2024 and averaged $139.7 million.
  • Data for Novavax's Change in Acquisitions & Divestments shows a maximum YoY plummeted of 92.44% (in 2021) over the last 5 years.
  • Over the past 3 years, Novavax's Change in Acquisitions & Divestments (Quarterly) stood at $2.2 million in 2021, then reached $337.9 million in 2024, then decreased by 4.84% to $100.5 million in 2025.
  • Its Change in Acquisitions & Divestments was $100.5 million in Q3 2025, compared to $111.6 million in Q2 2025 and $43.0 million in Q1 2025.